City of Philadelphia - File #: 060647

• File #: 060647
• Version: 0
• Type: Resolution
• Status: ADOPTED
• File created: 9/14/2006
• In control: CITY COUNCIL
• Final action: 9/14/2006
• Title: Recognizing October 7th as Multiple Myeloma Awareness Day.
• Sponsors: Councilmember Tasco, Councilmember Tasco, Councilmember Goode, Councilmember Goode, Councilmember Reynolds Brown, Councilmember Reynolds Brown, Councilmember Clarke, Councilmember Clarke, Councilmember Kelly, Councilmember Kelly, Councilmember Rizzo, Councilmember Miller, Councilmember Miller, Councilmember DiCicco, Councilmember DiCicco, Councilmember Krajewski, Councilmember Ramos, Councilmember Blackwell, Councilmember Blackwell, Councilmember Kenney, Councilmember Kenney, Councilmember O'Neill, Councilmember O'Neill, Council President Verna, Council President Verna

Date	Ver.	Action By	Action	Result	Tally
9/14/2006	0	CITY COUNCIL	ADOPTED
9/14/2006	0	CITY COUNCIL	ADOPTED
9/14/2006	0	CITY COUNCIL	READ
9/14/2006	0	CITY COUNCIL	READ
9/14/2006	0	CITY COUNCIL	Introduced	Pass
9/14/2006	0	CITY COUNCIL	Introduced	Pass

Title
Recognizing October 7th as Multiple Myeloma Awareness Day.
Body
WHEREAS, The Multiple Myeloma Research Foundation will be hosting its third annual "Race for Research" 5K Walk/Run on Saturday, October 7th at 9:00 a.m. at Memorial Hall in Fairmount Park; and

WHEREAS, Multiple Myeloma is a cancer of the plasma cells in the bone marrow, which help the body to detect and attack foreign substances like toxins, viruses, bacteria, and parasites that may have entered one's body; and

WHEREAS, The exact cause of Multiple Myeloma has not been identified, however, researchers have gained a greater understanding of how specific changes in DNA can cause plasma cells to become more cancerous; and

WHEREAS, A number of risk factors for this disease have been identified, including age and having other plasma cell diseases, and common signs and symptoms of Multiple Myeloma vary based on the extent of the disease and include bone pain, fatigue, weakness, and recurrent infections; and

WHEREAS, Multiple Myeloma may be first detected in routine blood tests, however, additional tests, including bone marrow tests, may be necessary to verify the diagnosis. The treatment and prognosis for the disease depends on various factors including its stage and the patient's age and treatment may include bone marrow/stem cell transplantation, chemotherapy, and radiation therapy; and

WHEREAS, According to the American Cancer Society, approximately 15,980 new cases of Multiple Myeloma will be diagnosed in the United States in 2005 and the disease is the second most common blood cancer and third fastest growing cancer in terms of mortality in people over the age of 65; and

WHEREAS, African Americans have the highest reported incidence of Multiple Myeloma and it is one of the top 10 leading causes of cancer death over the past three years; now therefore

RESOLVED...